CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry.
Cytometry A
; 81(1): 17-24, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-22052678
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
B-Lymphocytes
/
Biomarkers
/
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
/
Neoplasm, Residual
/
Neuropilin-1
/
Flow Cytometry
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cytometry A
Year:
2012
Type:
Article
Affiliation country:
France